治疗脑癌的 псилоцибин辅助疗法与存在的痛苦有关:一个案例报告
Jean-François Stephan1, Sani Karam1
1Department of Family Medicine, McGill University, Montreal, Canada.
Journal of palliative medicine
|September 12, 2024
概括
松素辅助疗法 (PAT) 显示出缓解脑癌患者生命末期痛苦的前景. 这个案例研究突出了PATAT的重点.
科学领域:
- 抚慰性护理是一种缓解性护理.
- 神经瘤学神经瘤学
- 精神病学是一个精神病学.
背景情况:
- 松素辅助疗法 (PAT) 正在成为息治疗中的存在性痛苦的治疗方法.
- 患有脑癌的患者,特别是那些像星细胞瘤这样的晚期患者,经常经历显著的心理痛苦,但经常被排除在临床研究之外.
- 绝症中的存在性痛苦可能是深刻的,通常是标准治疗不够解决的.
研究的目的:
- 报告 psilocybin 辅助疗法 (PAT) 的疗效和安全性,该疗法适用于因4期星细胞瘤而导致生命末期痛苦的患者.
- 突出PAT对大脑癌症患者的潜在好处,这些患者通常被排除在研究之外.
- 倡导扩大PAT的使用范围,以帮助患有未解决存在困境的患者.
主要方法:
- 一份病例报告详细介绍了PAT给患有4期星系细胞瘤的患者的使用情况,该患者正在经历生命末期的痛苦.
- 通过加拿大卫生部的特殊访问计划访问了PAT.
- 监测患者对治疗的反应,包括心理痛苦水平和不良事件.
主要成果:
- 患者对松素辅助疗法产生了积极的反应,存在性痛苦的部分缓解.
- 在PAT给药期间或之后没有报告任何不良事件.
- 该案例证明了PAT在经常被排除在研究之外的人群中的潜在实用性.
结论:
- 松素辅助疗法可以成为治疗脑癌患者存在性痛苦的有效选择.
- 目前对PAT的访问是有限的,特别是对脑癌患者来说,迫切需要扩大可用性.
- 增加对PAT的访问可能为考虑因未经治疗的痛苦而死亡的医疗援助的患者提供了替代方案.
相关概念视频
01:30Psychosurgery
47
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
47
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
01:30Electroconvulsive Therapy
29
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
29
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K